Zacks Investment Research | Jan 09, 2020 05:52AM ET
Shares of Varian (NYSE:VAR) scaled a new 52-week high of $147.06 on Jan 8, closing the session marginally lower at $146. In fact, the stock has rallied nearly 10.9% since its fourth-quarter fiscal 2019 earnings announcement on Nov 22.
Solid growth in core oncology segment, profitable acquisitions and a solid guidance for fiscal 2020 have prompted the rally.
Let us take a closer look at the factors driving growth.
Robust Q4 Earnings
The company exited the fourth quarter of fiscal 2019 on a promising note, with earnings meeting the Zacks Consensus Estimate and revenues surpassing the same. Revenues at the oncology segment rose 8.5% during the quarter driven by a surge in gross orders and expansion of net installed base.
Gross margin in the reported quarter was up 150 bps, while operating margin expanded 50 bps.
The lifted revenue outlook for fiscal 2020 buoys optimism among investors, indicating the continuation of this bullish trend through the year.
Other Encouraging Factors
Market has been upbeat about Varian’s recent acquisition of Cancer Treatment Services International. The collaboration is expected to boost Varian Medical’s core Oncology Systems business.
The company also recently announced an asset purchase agreement to acquire Boston Scientific’s portfolio of drug-loadable microsphere and bland embolic bead products for $90 million. This will strengthen Varian’s interventional oncology segment. Investors have also been optimistic about the company’s prospects since it announced the acquisitions of CyberHeart, Endocare and Alicon.
Meanwhile, Varian has been having a great run on the bourses in the past year. The stock has rallied 18.4% versus the broader Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.